Thrivent Financial For Lutherans Abiomed Inc Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $3,394 - $4,220	14 Added 0.7%	2,022 $497,000
Q2 2022 Aug 16, 2022	SELL	$224.73 - $338.64 $651,717 - $982,056	-2,900 Reduced 59.09%	2,008 $497,000
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $807,906 - $1.07 Million	2,914 Added 146.14%	4,908 $1.71 Million
Q4 2021 Feb 16, 2022	SELL	$300.63 - $371.35 $1.31 Million - $1.62 Million	-4,365 Reduced 68.64%	1,994 $716,000
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $1,240 - $1,504	-4 Reduced 0.06%	6,359 $2.01 Million
Q2 2021 Sep 24, 2021	BUY	$262.71 - $351.17 $1.15 Million - $1.54 Million	4,381 Added 221.04%	6,363 $1.99 Million
Q2 2021 Aug 19, 2021	SELL	$262.71 - $351.17 $1.15 Million - $1.53 Million	-4,363 Reduced 68.76%	1,982 $619,000
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $2,573 - $3,196	-9 Reduced 0.14%	6,345 $2.02 Million
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $260,695 - $335,547	1,035 Added 19.46%	6,354 $2.06 Million
Q3 2020 Nov 10, 2020	SELL	$255.22 - $317.0 $287,632 - $357,259	-1,127 Reduced 17.48%	5,319 $1.47 Million
Q2 2020 Aug 12, 2020	BUY	$141.4 - $257.09 $2,545 - $4,627	18 Added 0.28%	6,446 $1.14 Million
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $391 - $588	3 Added 0.05%	6,428 $933,000
Q4 2019 Feb 13, 2020	SELL	$159.31 - $223.54 $2.75 Million - $3.86 Million	-17,251 Reduced 72.86%	6,425 $1.1 Million
Q3 2019 Nov 14, 2019	SELL	$175.89 - $279.23 $3.74 Million - $5.93 Million	-21,249 Reduced 47.3%	23,676 $4.21 Million
Q2 2019 Aug 13, 2019	BUY	$250.96 - $284.94 $34,130 - $38,751	136 Added 0.3%	44,925 $11.7 Million
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $247,092 - $323,851	894 Added 2.04%	44,789 $12.8 Million
Q4 2018 Feb 15, 2019	BUY	$281.08 - $444.25 $7.84 Million - $12.4 Million	27,910 Added 174.6%	43,895 $14.8 Million
Q3 2018 Nov 15, 2018	BUY	$354.53 - $449.75 $283,269 - $359,350	799 Added 5.26%	15,985 $7.19 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $9.33 Million - $15 Million	-33,566 Reduced 68.85%	15,186 $6.21 Million
Q1 2018 May 08, 2018	SELL	$192.49 - $295.85 $4.08 Million - $6.27 Million	-21,183 Reduced 30.29%	48,752 $14.2 Million
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $1.77 Million - $2.1 Million	-10,505 Reduced 13.06%	69,935 $13.1 Million
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $11.7 Million - $13.6 Million	80,440	80,440 $13.6 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account